Finance

Lists
Why is BEAM up 16.16%?
Dive Deeper
BEAM:BMV
Beam Therapeutics Inc
MX$492.00
+16.16%
(+68.45) 1D
Nov 10, 10:08:16 AM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for BEAM...
Mkt. cap
2.17B
Avg. vol.
6.00
Volume
0.00
52-wk high
MX$663.44
52-wk low
MX$384.79
No. of employees
557
Mkt. cap
2.17B
Avg. vol.
6.00
Volume
0.00
52-wk high
MX$663.44
52-wk low
MX$384.79
No. of employees
557
News stories
From web sources and news partners
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc
CEOJohn Evans
Employees557
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitebeamtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
114.11M
31.74M
490.00K
307.00K
Cost of goods sold
99.28M
104.52M
95.10M
110.11M
Cost of revenue
99.28M
104.52M
95.10M
110.11M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32.28M
34.43M
31.95M
31.52M
Operating expense
32.28M
34.43M
31.95M
31.52M
Total operating expenses
131.55M
138.95M
127.04M
141.63M
Operating income
-17.44M
-107.22M
-126.55M
-141.32M
Other non operating income
50.00K
2.50M
-4.20M
4.70M
EBT including unusual items
244.30M
-94.32M
-122.68M
-134.40M
EBT excluding unusual items
-6.76M
-94.85M
-123.27M
-130.53M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
244.30M
-94.32M
-122.68M
-134.40M
Net profit margin
214.09%
-297.18%
-25,036.33%
-43,780.13%
Earnings per share
2.33
-0.91
-1.18
-1.28
Interest and investment income
10.64M
9.87M
10.16M
8.82M
Interest expense
-
-
-2.67M
-2.72M
Net interest expenses
10.64M
9.87M
7.49M
6.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.78M
-101.61M
-121.14M
-135.88M
Gain or loss from assets sale
-
-
44.00K
-1.00K
Upcoming events
AI content may include mistakes. Learn more
Google apps